HC Wainwright Cuts Tempus AI (NASDAQ:TEM) Price Target to $89.00

Tempus AI (NASDAQ:TEM) had its price objective decreased by analysts at HC Wainwright from $98.00 to $89.00 in a report released on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target would suggest a potential upside of 29.21% from the company’s current price.

Other equities analysts have also issued research reports about the company. Morgan Stanley boosted their target price on Tempus AI from $65.00 to $68.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 12th. Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a research report on Wednesday, October 8th. Guggenheim raised their price objective on shares of Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 26th. TD Cowen cut shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 price target on the stock. in a research note on Tuesday, October 21st. Finally, Piper Sandler lifted their target price on Tempus AI from $70.00 to $105.00 and gave the company a “neutral” rating in a research report on Wednesday, October 22nd. Seven research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $79.85.

Tempus AI Stock Down 4.5%

TEM traded down $3.21 on Friday, hitting $68.88. The company had a trading volume of 1,726,981 shares, compared to its average volume of 11,437,062. The stock has a fifty day simple moving average of $85.99 and a 200-day simple moving average of $70.61. The company has a debt-to-equity ratio of 2.45, a current ratio of 3.28 and a quick ratio of 1.43. The firm has a market capitalization of $11.97 billion, a P/E ratio of -57.23 and a beta of 4.86. Tempus AI has a 52-week low of $31.36 and a 52-week high of $104.32.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.05. The company had revenue of $334.21 million during the quarter, compared to analysts’ expectations of $328.89 million. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. Tempus AI’s revenue was up 84.7% on a year-over-year basis. During the same period last year, the company posted ($0.46) EPS. Tempus AI has set its FY 2025 guidance at EPS. As a group, equities analysts expect that Tempus AI will post -6.15 EPS for the current fiscal year.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, COO Ryan Fukushima sold 17,460 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $1,303,389.00. Following the completion of the sale, the chief operating officer directly owned 839,180 shares in the company, valued at approximately $62,644,787. This represents a 2.04% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the firm’s stock in a transaction dated Thursday, September 25th. The shares were sold at an average price of $76.56, for a total transaction of $25,456,200.00. Following the transaction, the chief executive officer directly owned 9,141,032 shares in the company, valued at $699,837,409.92. This trade represents a 3.51% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 1,105,282 shares of company stock valued at $87,726,381. 26.27% of the stock is owned by company insiders.

Institutional Investors Weigh In On Tempus AI

Hedge funds and other institutional investors have recently bought and sold shares of the company. Bank of New York Mellon Corp boosted its position in shares of Tempus AI by 27.5% in the 1st quarter. Bank of New York Mellon Corp now owns 60,965 shares of the company’s stock worth $2,941,000 after purchasing an additional 13,142 shares in the last quarter. Envestnet Asset Management Inc. boosted its stake in Tempus AI by 37.0% in the 1st quarter. Envestnet Asset Management Inc. now owns 60,447 shares of the company’s stock worth $2,916,000 after purchasing an additional 16,328 shares in the last quarter. Brown Advisory Inc. purchased a new stake in Tempus AI during the 1st quarter worth approximately $209,000. Axxcess Wealth Management LLC raised its holdings in shares of Tempus AI by 17.5% in the first quarter. Axxcess Wealth Management LLC now owns 7,709 shares of the company’s stock worth $372,000 after buying an additional 1,148 shares during the last quarter. Finally, Diversify Wealth Management LLC acquired a new stake in shares of Tempus AI during the first quarter worth $2,593,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.